全文获取类型
收费全文 | 49978篇 |
免费 | 4629篇 |
国内免费 | 1920篇 |
专业分类
耳鼻咽喉 | 98篇 |
儿科学 | 2283篇 |
妇产科学 | 172篇 |
基础医学 | 2719篇 |
口腔科学 | 175篇 |
临床医学 | 8187篇 |
内科学 | 12076篇 |
皮肤病学 | 293篇 |
神经病学 | 1490篇 |
特种医学 | 1266篇 |
外国民族医学 | 5篇 |
外科学 | 4254篇 |
综合类 | 9990篇 |
现状与发展 | 13篇 |
一般理论 | 1篇 |
预防医学 | 2409篇 |
眼科学 | 524篇 |
药学 | 5120篇 |
68篇 | |
中国医学 | 2907篇 |
肿瘤学 | 2477篇 |
出版年
2024年 | 137篇 |
2023年 | 1023篇 |
2022年 | 1271篇 |
2021年 | 2910篇 |
2020年 | 2480篇 |
2019年 | 1838篇 |
2018年 | 1693篇 |
2017年 | 1801篇 |
2016年 | 2057篇 |
2015年 | 1966篇 |
2014年 | 3280篇 |
2013年 | 3645篇 |
2012年 | 2933篇 |
2011年 | 3158篇 |
2010年 | 2500篇 |
2009年 | 2272篇 |
2008年 | 2307篇 |
2007年 | 2440篇 |
2006年 | 2213篇 |
2005年 | 2122篇 |
2004年 | 1919篇 |
2003年 | 1847篇 |
2002年 | 1128篇 |
2001年 | 1011篇 |
2000年 | 906篇 |
1999年 | 678篇 |
1998年 | 625篇 |
1997年 | 580篇 |
1996年 | 525篇 |
1995年 | 454篇 |
1994年 | 375篇 |
1993年 | 274篇 |
1992年 | 269篇 |
1991年 | 211篇 |
1990年 | 154篇 |
1989年 | 182篇 |
1988年 | 168篇 |
1987年 | 128篇 |
1986年 | 123篇 |
1985年 | 212篇 |
1984年 | 133篇 |
1983年 | 94篇 |
1982年 | 108篇 |
1981年 | 95篇 |
1980年 | 67篇 |
1979年 | 64篇 |
1978年 | 46篇 |
1977年 | 36篇 |
1976年 | 29篇 |
1975年 | 17篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Masahiro Fukuyama Misaki Kinoshita-Ise Yohei Sato Manabu Ohyama 《The Journal of dermatology》2020,47(6):583-591
The term “acute diffuse and total alopecia” (ADTA) has been often used as a synonym for self-regressing severe alopecia areata (AA). However, ADTA is originally defined as a rapidly-progressive subtype of AA (RP-AA) with short recovery time and favorable prognosis irrespective of interventions. Indeed, a subpopulation of ADTA recovers spontaneously. We focused on this unique subset of AA, which we coined as “self-healing ADTA” (sADTA). Prompt and accurate differentiation of sADTA from other RP-AA is important to avoid unnecessary treatments, which is still challenging due to the lack of predictive diagnostic hallmarks. In this study, 18 sADTA patients were retrospectively analyzed to delineate their demographics and clinical features, including gentle hair pull test and trichoscopic findings, followed by statistical comparison with those of RP-AA. All sADTA cases were female and the average age was 38.1 ± 15.9 years. The progression of hair loss areas peaked at 3.6 ± 1.5 months, and complete hair regrowth was achieved in 7.9 ± 1.7 months. The identified factors supporting the diagnosis of sADTA included being female; the absence of scalp pain and itch; the absence of extra-scalp hair loss; club hair predominance in hair pull test; predominant short vellus hairs; and increase in vacant follicular ostia on trichoscopy. Subsequently, a scoring system for early diagnosis of sADTA was developed by counting the number of six identified factors present in a tested case. When analyzed by the developed system, all sADTA cases, including an additional four cases, had scores of 4 or above, while all RP-AA cases had scores below 3 except one case. Therefore, the system successfully differentiated sADTA from RP-AA (P < 0.01). Despite some technical limitations, the current study suggested that sADTA is a distinctive entity with unique pathophysiology and that early diagnosis before intervention is feasible based on the characteristics. 相似文献
992.
993.
《Journal of the American College of Cardiology》2020,75(5):498-508
BackgroundLong-term cardiovascular and limb outcomes after revascularization for peripheral artery disease and, in particular, prognosis after post-procedure major adverse limb events (MALE) are not well-studied.ObjectivesThis study sought to describe outcomes after peripheral revascularization and assess relationships between post-procedure MALE hospitalization and subsequent events.MethodsPatients undergoing peripheral artery revascularization between January 1, 2009, and September 30, 2015, in the Premier Healthcare Database were examined for the co-primary outcomes of interest, composite myocardial infarction (MI) or stroke and composite major amputation or peripheral revascularization. Multivariable adjusted Cox proportional hazards models with post-procedure MALE hospitalization included as a time-dependent covariate were developed to estimate hazard ratios for outcomes.ResultsAmong 393,017 revascularized patients followed for a median of 2.7 years (interquartile range: 1.3 to 4.4 years), the cumulative incidence of MI or stroke was 9.8% and that of major amputation or peripheral revascularization was 41.9%. A total of 50,750 patients (12.9%) had at least 1 post-procedure MALE hospitalization. In time-dependent covariate adjusted models, post-procedure MALE hospitalization was associated with greater risk of subsequent MI or stroke (hazard ratio: 1.34; 95% confidence interval: 1.28 to 1.40) and major amputation or peripheral revascularization (hazard ratio: 8.13; 95% confidence interval: 7.96 to 8.29). After peripheral revascularization with or without post-procedure MALE hospitalization, risk of limb events increased rapidly post-procedure and more slowly after the first year, whereas cardiac risk increased steadily during follow-up.ConclusionsRevascularized peripheral artery disease patients face earlier limb and later cardiovascular ischemic risk that is heightened among patients with post-procedure MALE hospitalization. Increased provider awareness of these long-term risks may guide efforts to improve post-procedural outcomes. 相似文献
994.
995.
目的探讨急性缺血性脑卒中血管内治疗的方法、疗效和安全性。方法回顾性分析血管内治疗的大血管闭塞的急性缺血性脑卒中患者21例。10例为阿替普酶静脉溶栓后桥接血管内治疗,11例直接行血管内治疗。其中机械取栓12例,机械取栓+支架植入3例,单纯颈动脉支架植入3例,机械取栓+动脉溶栓1例,机械取栓+动脉溶栓+支架植入1例,单纯动脉溶栓1例。评估术中mTICI再通等级、并发症及术后随访第90天m RS评分,分析疗效与安全性。结果21例患者前循环卒中18例,后循环卒中3例。NIHSS评分平均15. 81±6. 44分。20例患者术后血管再通达mTICI 2 b-3级。术中并发出血1例,术后大量颅内出血1例,无症状少量颅内出血4例。术后高灌注综合征8例,其中4例行去骨瓣减压术,最终死亡5例(23. 81%)。术后随访第90天mRS评分0~2分8例。结论经充分评估并及时采取适宜的单一或多种血管内治疗方法对于大血管闭塞导致的急性缺血性脑卒中患者安全有效。 相似文献
996.
997.
《The Journal for Nurse Practitioners》2021,17(6):687-690
ST-segment elevation myocardial infarction (STEMI) is characterized by ST-segment elevation in at least 2 contiguous leads, chest discomfort, and the release of biomarkers requiring emergent revascularization. In 2013, the American College of Cardiology Foundation/American Heart Association revised STEMI guidelines to include augmented vector right (aVR) ST-segment elevation to be treated as a STEMI equivalent. However, aVR ST-segment elevation with multilead ST depression can occur in presentations other than occlusive myocardial infarctions. The purpose of this clinical feature is to provide a brief review of aVR ST-segment elevation, explore approaches to clinical decision making, and provide tools to support nurse practitioners caring for patients with cardiac issues. 相似文献
998.
目的研究鸦胆子油软胶囊联合SOX方案(奥沙利铂+替吉奥)治疗晚期结直肠癌的临床疗效。方法选取2018年8月-2019年8月在郑州大学附属洛阳中心医院治疗的80例晚期结直肠癌患者,所有患者随机分为对照组和治疗组,每组各40例。对照组患者入院后给予SOX方案治疗,第1~14天给予注射用奥沙利铂,推荐剂量130 mg/m^2,溶于500 mL 5%葡萄糖溶液中,输注时间小于3h;第1~21天口服替吉奥胶囊,1粒/次,2次/d。治疗组在对照组基础上口服鸦胆子油软胶囊,4粒/次,3次/d。21 d为1个治疗疗程,两组患者接受治疗3个疗程。观察两组的临床疗效,比较Karnofsky(KPS)评分、生活质量(QOL)评分及血清癌胚抗原(CEA)、基质金属蛋白酶(MMP)-2和MMP-9水平。结果经过治疗后,治疗组客观缓解率(ORR)和疾病控制率(CBR)显著高于对照组(P<0.05)。治疗后,两组患者KPS评分和QOL评分显著升高(P<0.05),且治疗组KPS评分和QOL评分升高程度较大(P<0.05)。治疗后,两组CEA、MMP-2和MMP-9水平显著降低(P<0.05);并且治疗组降低较多(P<0.05)。治疗组胃肠道反应、血小板减少、白细胞减少和转氨酶升高等不良反应发生率明显低于对照组(P<0.05)。结论鸦胆子油软胶囊联合SOX方案治疗晚期结直肠癌具有较好的治疗效果,能够提高患者生活质量,降低肿瘤标志物水平,安全性较高,值得在临床上推广应用。 相似文献
999.
目的 促进慢性阻塞性肺疾病急性加重期(AECOPD)患者肺康复。
方法 按急诊就诊时间将82例AECOPD患者分为对照组40例、观察组42例,两组均予常规治疗及护理,在此基础上对照组行常规肺康复措施;观察组组建多学科肺康复团队、制订和实施为期4周的三阶段肺康复方案。
结果 干预后,观察组患者的肺功能指标、动脉血氧饱和度、上下肢运动耐力评分、日常生活活动能力评分显著高于对照组,焦虑抑郁评分显著低于对照组(均P<0.05)。
结论 多学科协作下急诊科联合病房早期分阶段肺康复方案可有效改善AECOPD患者肺功能及运动耐力,从而改善患者心身状态。 相似文献
1000.
目的 探讨集束化护理干预在重症急性胰腺炎患者中的应用效果及对护理质量的影响。方法 选取2017年4月—2018年5月在我院进行治疗的重症急性胰腺炎患者96例,按照随机数字表法的分组方法,将其分为对照组和观察组,每组各48例。对照组患者采用常规护理干预,观察组患者采用集束化护理干预,观察分析患者的腹痛消失时间、发热持续时间、平均住院时间及护理满意程度。结果 观察组患者腹痛消失时间、发热持续时间及平均住院时间(5.63±1.12、3.68±0.52、17.59±2.67)均低于对照组(9.31±3.25、6.84±1.73、24.18±4.20),差异有统计学意义(t=7.417、12.119、9.174,P均=0.000);护理后,观察组患者护理满意程度(95.83%)均高于对照组(64.58%),差异有统计学意义(t=14.764,P=0.000)。结论 对重症急性胰腺炎患者给予集束化护理效果较好,可有效促进患者的病情康复,使护理质量得到提升。 相似文献